| Name | SymBio Pharmaceuticals Limited | ||
| Address | Toranomon 30 Mori Bldg., 3-2-2 Toranomon, Minato-ku, Tokyo 105-0001, Japan Tel: +81-3-5472-1125 Fax: +81-3-5472-3054 For inquiry about brincidofovir: +81-3-6684-6663 |
||
| Established | March 25, 2005 | ||
| Capital | JPY17,146,833,429 (as of the end of June / 2021) | ||
| Board of Directors |
Fuminori Yoshida Shigetoshi Matsumoto Bruce David Cheson Eiji Ebinuma |
Representative Director Board Director <Outside> Board Director <Outside> Board Director <Outside> |
|
| Auditors |
Kiyoshi Watanabe Kesao Endo Yasuhiro Tamo |
Full-Time Audit & Supervisory Board Member<Outside> Audit & Supervisory Board Member<Outside> Audit & Supervisory Board Member<Outside> |
|
| Corporate Officers |
Fuminori Yoshida Takaaki Kishida Takaaki Fukushima Kozo Yoshida Masayuki Aboshi Yoshiharu Torikai |
Corporate Officer, President and Chief Executive Officer Corporate Officer, Chief Financial Officer Corporate Officer Corporate Officer Corporate Officer Corporate Officer |
|
| Subsidiary | SymBio Pharma USA, Inc. Durham, North Carolina, USA |
||
